why choose us

Clinical Trials Search

Showing 17,810 of 132,963 result(s)
Comparing Suprainguinal Fascia Iliaca Block With Erector Spinae Plain Block in Hip and Proximal Femur Surgery

Status: Active, not recruiting

Condition: Postoperative Pain
Femur Fracture
Regional Anesthesia

Interventions: Procedure: Regional Block Comparison
Comparing postoperative pain and opioid consumption in groups

Date: 2022-11-30

Stress Reduction and Atherosclerotic CVD in African Americans

Status: Completed

Condition: Atherosclerosis, Cerebral

Interventions: Interventional

Date: 2022-11-30

A Study of Single-dose MY008211A in Healthy Adults

Status: Active, not recruiting

Condition: Paroxysmal Nocturnal Hemoglobinuria

Interventions: Interventional

Date: 2022-11-30

Phase Ia Study of XW001 in Healthy Adult Subjects

Status: Completed

Condition: Respiratory Syncytial Virus Infections

Interventions: Interventional

Date: 2022-11-30

A Bioequivalence Study of Dasatinib Tablet

Status: Completed

Condition: Leukemia, Myelogenous, Chronic

Interventions: Interventional

Date: 2022-11-30

Weight Loss in Patients With COVID-19 and Influenza in Comorbidity With NCDs: a Pilot Prospective Clinical Trial

Status: Completed

Condition: Clinical Trial

Interventions: Interventional

Date: 2022-11-30

Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Status: Completed

Condition: COVID-19

Interventions: Interventional

Date: 2022-11-30

Inspiratory Muscle Strength Training in Adults With Type 2 Diabetes

Status: Completed

Condition: Diabetes Mellitus, Type 2

Interventions: 30 breaths;day, 5 days;week, 6 weeks

Date: 2022-11-30

Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) Study in Ulcerative Colitis

Status: Completed

Condition: Ulcerative Colitis

Interventions: Respiratory-Gated Auricular Vagal Afferent Nerve Stimulation

Date: 2022-11-30

Investigating the Effects of Cannabidiol on Social Anxiety Disorder

Status: NOT_YET_RECRUITING

Condition: Phobia, Social

Interventions: Participants randomized to the cannabidiol arm will receive 3mL of Epidiolex (100mg cannabidiol;mL) in a single-dose.

Date: 2022-11-30